Bumetanide

Bumetanide, sold as Bumex, is a loop diuretic, a medicine taken by mouth that acts on the kidney. The US label read, for Bumex tablets, lists swelling from fluid build-up in people with congestive heart failure, liver disease and kidney disease, including the nephrotic syndrome. The label carries a boxed warning that the medicine is a potent diuretic and, in excessive amounts, can lead to a profound loss of water and salts from the body.

Also called Bumex

  • Drug
  • In this atlas

Overview

Technical summary

RxNorm ingredient 1808; UNII 0Y2S3XUQ5H. MeSH descriptor D002034 is Bumetanide. Class: Loop Diuretic (FDA established pharmacologic class, RxClass). The label read is the Validus Pharmaceuticals LLC label for Bumex tablets, application NDA018225, effective 2025-09-08 in openFDA. Bumetanide injection labels (for example ANDA applications) and generic labels were not read. The label says safety and effectiveness in patients under 18 have not been established; that statement was not recorded as a claim. This page records label indications, the title and first sentence of the boxed warning, the mechanism sentence and the class only: no trial result and no dose is given.

About this drug

Level
Substance
Mechanism
The label says bumetanide inhibits sodium reabsorption in the ascending limb of the loop of Henle.

Claims and evidence

Context Patients with edema from congestive heart failure, liver disease or kidney disease, as described in the US label of Bumex tablets

Recipient
Recipient not specified
Population
Patients described in the indications section of the label: people with edema associated with congestive heart failure, hepatic disease or renal disease, including the nephrotic syndrome. The passages read do not state an age range.
Care setting
Prescription medicine, as described in the US label
Geography
United States (label of the US Food and Drug Administration)
Life stage
Not stated in the label passages read
Gestational age
Not reported
Postnatal age
Not reported
Follow-up
Not applicable (label statement)
Eligibility: 1 inclusion criterion; exclusion criteria not stated
Included
  • Patients with edema associated with congestive heart failure, hepatic disease or renal disease, including the nephrotic syndrome
Excluded
None stated
  • Description Evidence stage not applicable Certainty not assessed

    The US label of Bumex (bumetanide tablets, Validus Pharmaceuticals LLC, application NDA018225; the version dated 2025-09-08 in openFDA) lists the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. It describes bumetanide as a loop diuretic. The label carries a boxed warning that the medicine is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion.

    Applies to Recipient not specified Patients with edema from congestive heart failure, liver disease or kidney disease, as described in the US label of Bumex tablets

    Certainty method
    Not assessed
    Limitations
    This claim records what one US label says the medicine is indicated for and the boxed warning's first sentence. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The boxed warning goes on to say what prescribers must do; that instruction is not repeated here. Contraindications, other warnings, interactions, the label's pediatric statement and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
    Last checked
    2026-11-18
    Next evidence check due
    Not scheduled
    Sources and citations (4)
    1. Supports openFDA drug label record for Bumex (bumetanide tablets), Validus Pharmaceuticals LLC label: indications, mechanism, class and boxed warning

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 32dfbea3-eb2b-4070-8605-57ce3e6d5a2f (manufacturer Validus Pharmaceuticals LLC, application NDA018225), returned on 2026-11-18. The label text is dated 2025-09-08 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], INDICATIONS AND USAGE
      How it applies
      Label passage quoted in the research quote table (LB-04).
      Retrieved
      Source effective date
      2025-09-08
      Source state
      Current
      Version fingerprint
      6097bcd5b6638cd4d11c8aea78439d1b9d73e8e69002fdc2f0399cadd90f1455
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    2. Supports openFDA drug label record for Bumex (bumetanide tablets), Validus Pharmaceuticals LLC label: indications, mechanism, class and boxed warning

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 32dfbea3-eb2b-4070-8605-57ce3e6d5a2f (manufacturer Validus Pharmaceuticals LLC, application NDA018225), returned on 2026-11-18. The label text is dated 2025-09-08 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].clinical_pharmacology[0], first sentence
      How it applies
      Label passage quoted in the research quote table (LB-05).
      Retrieved
      Source effective date
      2025-09-08
      Source state
      Current
      Version fingerprint
      6097bcd5b6638cd4d11c8aea78439d1b9d73e8e69002fdc2f0399cadd90f1455
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    3. Supports openFDA drug label record for Bumex (bumetanide tablets), Validus Pharmaceuticals LLC label: indications, mechanism, class and boxed warning

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 32dfbea3-eb2b-4070-8605-57ce3e6d5a2f (manufacturer Validus Pharmaceuticals LLC, application NDA018225), returned on 2026-11-18. The label text is dated 2025-09-08 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].boxed_warning[0], first sentence
      How it applies
      Label passage quoted in the research quote table (LB-06).
      Retrieved
      Source effective date
      2025-09-08
      Source state
      Current
      Version fingerprint
      6097bcd5b6638cd4d11c8aea78439d1b9d73e8e69002fdc2f0399cadd90f1455
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    4. Background openFDA drug label record for Bumex (bumetanide tablets), Validus Pharmaceuticals LLC label: indications, mechanism, class and boxed warning

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 32dfbea3-eb2b-4070-8605-57ce3e6d5a2f (manufacturer Validus Pharmaceuticals LLC, application NDA018225), returned on 2026-11-18. The label text is dated 2025-09-08 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].effective_time
      How it applies
      Effective date of the label text read, 20250908.
      Retrieved
      Source effective date
      2025-09-08
      Source state
      Current
      Version fingerprint
      6097bcd5b6638cd4d11c8aea78439d1b9d73e8e69002fdc2f0399cadd90f1455
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Record details

Record id
cardio:bumetanide
Content hash
d4dacfb3343cd13e17db6e2964c75fdd1284a8c7cfd111edf870e43c73e71515